American Teenagers Are Turning To Emergency Departments Because Of Ecstasy More Often.
The legions of US teens who twine up in the emergency cubicle after taking the club drug Ecstasy has more than doubled in recent years, raising concerns that the hallucinogen is back in vogue, federal officials promulgate Dec 2013. Emergency room visits related to MDMA - known as Ecstasy in crank form and Molly in the newer powder form - increased 128 percent between 2005 and 2011 surrounded by people younger than 21. Visits rose from about harshly 4500 to more than 10000 during that time, according to a report released Tuesday by the US Substance Abuse and Mental Health Services Administration.
And "This should be a wake-up bidding to everyone, but the tough nut to crack is much bigger than what the data show," said Steve Pasierb, president and CEO of The Partnership at Drugfree full stop org. "These are only the cases that roll into the emergency rooms. It's just the suggestion of the iceberg". The SAMHSA study comes on the heels of a string of Ecstasy-related deaths. Organizers closed the Electric Zoo music entertainment in New York City one day first in August following two deaths and four hospitalizations caused by Ecstasy overdoses.
The deaths came a week after another sophomoric man died from Ecstasy overdose at a rock show in Boston. Ecstasy produces feelings of increased vim and vigour and euphoria, and can distort a person's senses and perception of time. It innards by altering the brain's chemistry, but research has been inconclusive regarding the effects of long-term abuse on the brain.
However, joy abuse can cause potentially harmful physical reactions. Users can become dangerously overheated and wisdom rapid heartbeat, increased blood pressure and dehydration, all of which can lead to kidney or heart failure. Alcohol also appears to be a factor. One-third of the danger room visits involving Ecstasy also twisted alcohol, a combination that can cause a longer-lasting euphoria, according to SAMHSA.
Showing posts with label visits. Show all posts
Showing posts with label visits. Show all posts
Sunday 7 January 2018
Saturday 16 July 2016
Frequent Consumption Of Energy Drinks Can Lead To Poor Health
Frequent Consumption Of Energy Drinks Can Lead To Poor Health.
As the lionization of vim and vigour drinks has soared, so has the number of Americans seeking care in hospital emergency rooms after consuming these highly caffeinated beverages, federal health officials report. Between 2007 and 2011, the add of ER visits more than doubled from roughly 10000 to almost 21000. In 2011, 58 percent of these ER visits tortuous energy drinks alone, while 42 percent also included medicament or alcohol use. Most of these cases complicated teens or young adults, although there was an alarming spike in the number of people aged 40 and older showing up in the ER after consuming these drinks, according to the clock in from the US Substance Abuse and Mental Health Services Administration.
Symptoms ranged from insomnia, nervousness, headaches and rapid heartbeats to seizures. Energy drinks keep under control high amounts of caffeine that can stimulate both the central nervous system and cardiovascular system, experts note. Caffeine levels in spirit drinks range from about 80 milligrams (mg) to more than 500 mg in a can or bottle, the turn up noted, while a 5-ounce cup of coffee contains 100 mg of caffeine and a 12-ounce soda contains 50 mg of caffeine, the circulate said.
The beverages can also have other ingredients that may increase the stimulant effects of caffeine, according to report. Many doctors are vexed about the high levels of caffeine in energy drinks, which can cause a major increase in heart grade and drive up blood pressure, explained Dr Suzanne Steinbaum, a preventive cardiologist at Lenox Hill Hospital in New York City. "In anyone who has any underlying sentiment condition, these two clobber can be deadly," she told HealthDay recently. "Know what you're drinking before you drink it".
Dr Mary Claire O'Brien, a important expert on energy drinks from Wake Forest Baptist Medical Center in Winston Salem, NC, had this this to about about the findings. "The issue is not the doubling of pinch department visits. That is the symptom," O'Brien said. "The 'disease' is the lemon of the federal government to regulate energy drinks as beverages".
As the lionization of vim and vigour drinks has soared, so has the number of Americans seeking care in hospital emergency rooms after consuming these highly caffeinated beverages, federal health officials report. Between 2007 and 2011, the add of ER visits more than doubled from roughly 10000 to almost 21000. In 2011, 58 percent of these ER visits tortuous energy drinks alone, while 42 percent also included medicament or alcohol use. Most of these cases complicated teens or young adults, although there was an alarming spike in the number of people aged 40 and older showing up in the ER after consuming these drinks, according to the clock in from the US Substance Abuse and Mental Health Services Administration.
Symptoms ranged from insomnia, nervousness, headaches and rapid heartbeats to seizures. Energy drinks keep under control high amounts of caffeine that can stimulate both the central nervous system and cardiovascular system, experts note. Caffeine levels in spirit drinks range from about 80 milligrams (mg) to more than 500 mg in a can or bottle, the turn up noted, while a 5-ounce cup of coffee contains 100 mg of caffeine and a 12-ounce soda contains 50 mg of caffeine, the circulate said.
The beverages can also have other ingredients that may increase the stimulant effects of caffeine, according to report. Many doctors are vexed about the high levels of caffeine in energy drinks, which can cause a major increase in heart grade and drive up blood pressure, explained Dr Suzanne Steinbaum, a preventive cardiologist at Lenox Hill Hospital in New York City. "In anyone who has any underlying sentiment condition, these two clobber can be deadly," she told HealthDay recently. "Know what you're drinking before you drink it".
Dr Mary Claire O'Brien, a important expert on energy drinks from Wake Forest Baptist Medical Center in Winston Salem, NC, had this this to about about the findings. "The issue is not the doubling of pinch department visits. That is the symptom," O'Brien said. "The 'disease' is the lemon of the federal government to regulate energy drinks as beverages".
Tuesday 15 December 2015
Increased Risk Of Major And Minor Bleeding During Antiplatelet Therapy
Increased Risk Of Major And Minor Bleeding During Antiplatelet Therapy.
Risk of bleeding for patients on antiplatelet psychotherapy with either warfarin or a party of Plavix (clopidogrel) and aspirin is substantial, a redone study finds. Both therapies are prescribed for millions of Americans to interdict life-threatening blood clots, especially after a heart attack or stroke. But the Plavix-aspirin conjunction was thought to cause less bleeding than it actually does, the researchers say.
And "As with all drugs, these drugs come with risks; the most importance is bleeding," said lead author Dr Nadine Shehab, from the US Centers for Disease Control and Prevention (CDC). While the endanger of bleeding from warfarin is well-known, the risks associated with dual remedy were not well understood. "We found that the risk for hemorrhage was threefold higher for warfarin than for dual antiplatelet therapy. We expected that because warfarin is prescribed much more continually than dual antiplatelet therapy".
However, when the researchers took the billion of prescriptions into account, the gap between warfarin and dual antiplatelet group therapy shrank. "And this was worrisome". For both regimens, the number of hospital admissions because of bleeding was similar. And bleeding-related visits to predicament department visits were only 50 percent decrease for those on dual antiplatelet therapy compared with warfarin. "This isn't as big a difference as we had thought".
For the study, published Monday in the Archives of Internal Medicine, Shehab's yoke used national databases to pigeon-hole emergency department visits for bleeding caused by either dual antiplatelet therapy or warfarin between 2006 and 2008. The investigators found 384 annual exigency department visits for bleeding to each patients taking dual antiplatelet therapy and 2,926 annual visits for those taking warfarin.
Risk of bleeding for patients on antiplatelet psychotherapy with either warfarin or a party of Plavix (clopidogrel) and aspirin is substantial, a redone study finds. Both therapies are prescribed for millions of Americans to interdict life-threatening blood clots, especially after a heart attack or stroke. But the Plavix-aspirin conjunction was thought to cause less bleeding than it actually does, the researchers say.
And "As with all drugs, these drugs come with risks; the most importance is bleeding," said lead author Dr Nadine Shehab, from the US Centers for Disease Control and Prevention (CDC). While the endanger of bleeding from warfarin is well-known, the risks associated with dual remedy were not well understood. "We found that the risk for hemorrhage was threefold higher for warfarin than for dual antiplatelet therapy. We expected that because warfarin is prescribed much more continually than dual antiplatelet therapy".
However, when the researchers took the billion of prescriptions into account, the gap between warfarin and dual antiplatelet group therapy shrank. "And this was worrisome". For both regimens, the number of hospital admissions because of bleeding was similar. And bleeding-related visits to predicament department visits were only 50 percent decrease for those on dual antiplatelet therapy compared with warfarin. "This isn't as big a difference as we had thought".
For the study, published Monday in the Archives of Internal Medicine, Shehab's yoke used national databases to pigeon-hole emergency department visits for bleeding caused by either dual antiplatelet therapy or warfarin between 2006 and 2008. The investigators found 384 annual exigency department visits for bleeding to each patients taking dual antiplatelet therapy and 2,926 annual visits for those taking warfarin.
Monday 16 November 2015
Halving Appeal For Emergency Aid For Children Under Two Years
Halving Appeal For Emergency Aid For Children Under Two Years.
Three years after nonprescription infant head medicines were charmed off the market, crisis rooms treat less than half as many children under 2 for overdoses and other adverse reactions to the drugs, a callow US government study shows. A voluntary withdrawal of over-the-counter cough and numbing medicines for children aged 2 and under took effect in October 2007 because of concerns about quiescent harm and lack of effectiveness. The following year, the withdrawal was extended to medications intended for 4-year-olds, the researchers say.
And "I meditate it's good that these products were withdrawn, but it's not flourishing to take care of the entire problem," said lead researcher Dr Daniel S Budnitz, of the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC). Since more than two-thirds of these predicament unit visits were the result of young children getting into medicines on their own, problems are conceivable to continue. The report is published online Nov 22, 2010 in Pediatrics.
For the study, Budnitz's line-up tracked visits to US hospital emergency departments by children under 12 who were treated for adverse events tied to over-the-counter common cold medications in the 14 months before and after the withdrawal. Although the unmitigated number of visits remained the same before and after the withdrawal, among children under 2 these visits dropped from 2,790 to 1,248 - more than 50 percent, the researchers found.
But, as with danger section visits before the withdrawal, 75 percent of cases involving cold medications resulted from children taking these drugs while unsupervised. Whether these exigency department visits involved cough and hyperboreal medicines for children or adults isn't known.
Three years after nonprescription infant head medicines were charmed off the market, crisis rooms treat less than half as many children under 2 for overdoses and other adverse reactions to the drugs, a callow US government study shows. A voluntary withdrawal of over-the-counter cough and numbing medicines for children aged 2 and under took effect in October 2007 because of concerns about quiescent harm and lack of effectiveness. The following year, the withdrawal was extended to medications intended for 4-year-olds, the researchers say.
And "I meditate it's good that these products were withdrawn, but it's not flourishing to take care of the entire problem," said lead researcher Dr Daniel S Budnitz, of the Division of Healthcare Quality Promotion at the Centers for Disease Control and Prevention (CDC). Since more than two-thirds of these predicament unit visits were the result of young children getting into medicines on their own, problems are conceivable to continue. The report is published online Nov 22, 2010 in Pediatrics.
For the study, Budnitz's line-up tracked visits to US hospital emergency departments by children under 12 who were treated for adverse events tied to over-the-counter common cold medications in the 14 months before and after the withdrawal. Although the unmitigated number of visits remained the same before and after the withdrawal, among children under 2 these visits dropped from 2,790 to 1,248 - more than 50 percent, the researchers found.
But, as with danger section visits before the withdrawal, 75 percent of cases involving cold medications resulted from children taking these drugs while unsupervised. Whether these exigency department visits involved cough and hyperboreal medicines for children or adults isn't known.
Subscribe to:
Posts (Atom)